Table 1.

Main characteristics of the nine studies that will be conducted in Bosnia-Herzegovina, Colombia and Uganda

	Bosnia-Herzegovina	Colombia	Uganda
DIALOG+	Cluster RCT, 72 patients with depression and anxiety, 14 clinicians, Control group = TAU	Cluster RCT, 168 patients with SMI, 14 clinicians, Control group = TAU	Cluster RCT, 168 patients with MNS, 14 clinicians, Active control group
Family Involvement	RCT, 72 patients with SMI, 36–72 family members/friends, 6–12 clinicians, Control group = TAU	Non-controlled trial, 30 patients with SMI, 30–60 family members/friends, 6–12 clinicians, No control group	Controlled trial, 30 patients with SMI, 30–60 family members/friends, 6–12 clinicians, Control site
Volunteer Support	RCT, 72 patients with SMI, 36 Volunteers, Control group = TAU	Non-controlled trial, 30 patients with SMI, 20 volunteers, No control group	Controlled trial, 30 patients with SMI, 10 volunteers, Control Site

Abbreviations: RCT Randomised controlled trial, SMI Severe mental illness, MNS Mental, neurological and substance misuse disorders, TAU Treatment as usual